About Us

In order to successfully develop innovative drugs fulfilling large unmet medical needs, Oncorena is dedicated on having the right people in the right roles.


Lars Grundemar

Chief Executive Officer

MD, PhD. Former R&D leadership positions at Ferring, AstraZeneca, Novartis and Pharmacia Corporation in various countries in Europe and in the US across therapeutic areas, including Oncology. Adjunct professor Clinical Pharmacology, Lund University, Sweden.